Ticker brief
PRAX PRAXIS PRECISION MEDICINES I
Consumer, Non-cyclical · Biotechnology
last close
$344.75
1 day
-6.3%
14 days
-6.0%
mkt cap
$8.9B
signals 14d
11
authors 14d
4
crowd 14d
+2.1σ
Options inteloptions-surface reads · latest available day per source
| metric | reading | context |
|---|---|---|
| IV — ATM 30d | 57% cheap · 4 pctile own 1y | IV/HV 0.86× |
| Skew — 25Δ RR 30d | +0.069 99 pctile own 1y | calls bid vs puts (call skew rich) |
| Net dealer OI (NDOI) | -0.27 thin | 5-session Δ -0.19 (as of 2026-07-16) |
| OI alarm | quiet | last alarm 2025-12-08 (z=2.4) |
Sentiment — last 14 days
daily mean sentiment, 2026-08-17 → 2026-08-28 · now +0.85 (−1 bearish … +1 bullish)
Who spoke4
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @Biotech2k1 | A | +1.02 | 8 | +0.72 |
| @Quantumup1 | C | · | 1 | +0.40 |
| @SpartanTrading | C | -1.46 | 1 | +0.10 |
| @StockMKTNewz | C | +0.59 | 1 | +0.40 |
Recent signals11of 11 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-08-28 | @Biotech2k1 | +0.85 | Calls four biotech stocks materially undervalued versus explicit fair values | — | tweet ↗ |
| 2026-08-27 | @Biotech2k1 | +0.50 | Discloses a COGT purchase and explicit current/target portfolio weights for four biotech holdings. | -6.3% | tweet ↗ |
| 2026-08-26 | @Biotech2k1 | +0.85 | Says PRAX remains at half fair value and could be worth $800-$1,000 if both drugs win approval. | -8.6% | tweet ↗ |
| 2026-08-26 | @Biotech2k1 | +0.75 | Discloses a long-term PRAX core position accumulated from $37.35 to a $78.25 average cost. | -8.6% | tweet ↗ |
| 2026-08-26 | @Biotech2k1 | +0.80 | Plans to build core biotech names toward 10% each and add IDYA and COGT at good values. — Explicit portfolio-building plan specifies target weights and value-dependent additions. | -8.6% | tweet ↗ |
| 2026-08-25 | @Biotech2k1 | +0.60 | Explicitly discloses positions in three precommercial late-stage biotech companies. | -6.3% | tweet ↗ |
| 2026-08-25 | @Biotech2k1 | +0.80 | Added to INSM, PTGX, BBIO and PRAX for their long-term mega-cap pipeline potential. — Explicit additions are backed by pipeline upside and relative valuation. | -6.3% | tweet ↗ |
| 2026-08-20 | @StockMKTNewz | +0.40 | Lists stocks that reached new 52-week highs today; output is capped at six tickers. | -5.4% | tweet ↗ |
| 2026-08-19 | @SpartanTrading | +0.10 | Names four chart ideas on the next day's radar without entry intent. | -10.7% | tweet ↗ |
| 2026-08-19 | @Biotech2k1 | +0.60 | Discloses finalized core portfolio holdings and plans to sell positions that failed analysis into rallies | -10.7% | tweet ↗ |
| 2026-08-17 | @Quantumup1 | +0.40 | Raymond James reiterated Strong Buy and raised PRAX's target to $945 from $765. | -8.4% | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.